These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 24161374)
1. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents. Zaki M; Amr K Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374 [TBL] [Abstract][Full Text] [Related]
2. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102 [TBL] [Abstract][Full Text] [Related]
3. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219 [TBL] [Abstract][Full Text] [Related]
4. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598 [TBL] [Abstract][Full Text] [Related]
5. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome. Niculescu LS; Vlădică M; Sima AV Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis. Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study. Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083 [TBL] [Abstract][Full Text] [Related]
8. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients. Novotny D; Vaverkova H; Karasek D; Malina P Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297 [TBL] [Abstract][Full Text] [Related]
9. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level. Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748 [TBL] [Abstract][Full Text] [Related]
10. [Association of apolipoprotein A5 gene -1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus]. Zhai GH; Wen P; Guo LF; Chen L Yi Chuan; 2007 May; 29(5):541-6. PubMed ID: 17548321 [TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population. Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680 [TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels. Kim JY; Kim OY; Paik JK; Lee SH; Lee JH J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427 [TBL] [Abstract][Full Text] [Related]
13. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents. Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia. Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome. Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300 [TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622 [TBL] [Abstract][Full Text] [Related]
17. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels. Li YY; Yin RX; Lai CQ; Li M; Long XJ; Li KL; Liu WY; Zhang L; Wu JZ Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):947-56. PubMed ID: 20708914 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke. Can Demirdöğen B; Şahin E; Türkanoğlu Özçelik A; Bek S; Demirkaya Ş; Adali O Mol Biol Rep; 2012 Dec; 39(12):10459-68. PubMed ID: 23065249 [TBL] [Abstract][Full Text] [Related]